There are some studies that identify the risk between thrombosis and MMP9 levels.57,58 We also found positive correlation between the thrombotic event history, JAK2 mutation, and MMP9 polymorphism in the ET group (P = 0.006 and 0.02). This evidence concerns the gene JAK2 and essential thrombocythemia.